These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17331324)

  • 21. The influence of drug type on the release profiles from Surelease-coated pellets.
    Sadeghi F; Ford JL; Rajabi-Siahboomi A
    Int J Pharm; 2003 Mar; 254(2):123-35. PubMed ID: 12623188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
    Wang R; Huang G; Fang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.
    Gretić M; Štanfel M; Barbarić J; Rimac N; Matijašić G
    Eur J Pharm Biopharm; 2021 May; 162():70-81. PubMed ID: 33727144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation of Shuxiong pulsatile controlled-release dropping pill].
    Chen H; Chen YZ; Xie QC; Lin SY; Lin JC; Jianc WN
    Zhong Yao Cai; 2013 Jul; 36(7):1155-8. PubMed ID: 24417154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the release mechanism of Theophylline from pellets coated with Surelease
    Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of pH-dependent gradient-release pellets for TCM.
    Tang X; Tian X; Ci L
    Drug Dev Ind Pharm; 2004; 30(10):1079-87. PubMed ID: 15595574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 3: Applications for microcapsules.
    Rogers TL; Wallick D
    Drug Dev Ind Pharm; 2012 May; 38(5):521-39. PubMed ID: 21962077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet.
    Park CW; Kim JY; Rhee YS; Oh TO; Ha JM; Park ES
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1179-87. PubMed ID: 22200122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium.
    Swain S; Behera UA; Beg S; Sruti J; Patro ChN; Dinda SC; Rao ME
    Drug Dev Ind Pharm; 2013 Apr; 39(4):548-60. PubMed ID: 22512732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer.
    Chi N; Guo JH; Zhang Y; Zhang W; Tang X
    Pharm Dev Technol; 2010; 15(1):97-104. PubMed ID: 19671037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality by design: optimization of a liquid filled pH-responsive macroparticles using Draper-Lin composite design.
    Rafati H; Talebpour Z; Adlnasab L; Ebrahimi SN
    J Pharm Sci; 2009 Jul; 98(7):2401-11. PubMed ID: 19226624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical optimization of gastric floating system for oral controlled delivery of calcium.
    Li S; Lin S; Chien YW; Daggy BP; Mirchandani HL
    AAPS PharmSciTech; 2001 Jan; 2(1):E1. PubMed ID: 14727887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration.
    Shamma RN; Basalious EB; Shoukri RA
    Int J Pharm; 2011 Feb; 405(1-2):102-12. PubMed ID: 21145958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
    Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
    Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion.
    Vaithiyalingam S; Khan MA
    Int J Pharm; 2002 Mar; 234(1-2):179-93. PubMed ID: 11839449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.